Guillain-Barré syndrome is the most common cause of acute flaccid paralysis worldwide.
Most patients present with an antecedent illness, most commonly upper respiratory tract …

Guillain–Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of
the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of …

Abstract Reports of Guillain-Barré syndrome (GBS) have emerged during the Coronavirus
disease 2019 (COVID-19) pandemic. This epidemiological and cohort study sought to …

Objective To determine the prevalence and associated mortality of well-defined neurologic
diagnoses among patients with coronavirus disease 2019 (COVID-19), we prospectively …

Objective Single cases and small series of Guillain-Barré syndrome (GBS) have been
reported during the SARS-CoV-2 outbreak worldwide. We evaluated incidence and clinical …

Importance Postauthorization monitoring of vaccines in a large population may detect rare
adverse events not identified in clinical trials such as Guillain-Barré syndrome (GBS), which …

Background Little is known regarding long-term outcomes of patients hospitalized with
COVID-19. Methods We conducted a prospective study of 6-month outcomes of hospitalized …

Objective To identify the rates of neurological events following administration of mRNA
(Pfizer, Moderna) or adenovirus vector (Janssen) vaccines in the US Methods We used …

Guillain-Barré syndrome is the most common and most severe acute paralytic neuropathy,
with about 100 000 people developing the disorder every year worldwide. Under the …

Importance Because of historical associations between vaccines and Guillain-Barré
syndrome (GBS), the condition was a prespecified adverse event of special interest for …